Explore: Plasma Exchange

Greek πλάσμα, plasma, something molded, and ἀφαίρεσις aphairesis, taking away) is the removal, treatment, and return or exchange of blood plasma or components

supported by measuring activity of or antibodies against ADAMTS13. With plasma exchange the risk of death has decreased from more than 90% to less than 20%

damage, or died within the first year after diagnosis despite plasma exchange or plasma infusion (PE/PI). Clinical signs and symptoms of complement-mediated

proteins. It may also be used as the replacement fluid in plasma exchange. Using ABO compatible plasma, while not required, may be recommended. Use as a volume

cryodepleted plasma undergoing buffer exchange via either diafiltration or buffer exchange chromatography, to prepare the plasma for following ion exchange chromatography

renal replacement therapy (dialysis or kidney transplantation) and plasma exchange. Kidney problems can have significant impact on quality and length

production of autoantibodies. Plasma exchange – removal of the liquid portion of blood to remove harmful substances. The plasma is replaced with a replacement

azathioprine, methotrexate, or rituximab to keep the disease under control. Plasma exchange is also used in severe cases with damage to the lungs, kidneys, or

immunomodulatory therapies (intravenous immunoglobulin (IVIG) or therapeutic plasma exchange (TPE)) for PANS and PANDAS; most studies have methodological issues

treatments include corticosteroids (e.g., prednisone), and plasmapheresis (plasma exchange) which may be prescribed alone or in combination with an immunosuppressant